Welcome to our dedicated page for Ventas SEC filings (Ticker: VTR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ventas, Inc. (NYSE: VTR) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a healthcare-focused S&P 500 real estate investment trust. Through these filings, investors can review how Ventas reports on its portfolio of approximately 1,400 properties in North America and the United Kingdom, including senior housing communities, outpatient medical buildings, research centers and other healthcare facilities.
Current and historical Forms 8-K offer detailed information about material events affecting Ventas and its subsidiaries. Recent 8-K filings describe items such as the pricing and issuance of senior notes by Ventas Realty, Limited Partnership, amendments to unsecured term loan facilities guaranteed by Ventas, and announcements of quarterly results. These documents help readers understand the company’s capital structure, borrowing arrangements and operating performance disclosures.
Other SEC filings, such as annual reports on Form 10-K and quarterly reports on Form 10-Q, provide broader context on Ventas’s business, risk factors, REIT structure and segment performance. For a healthcare REIT like Ventas, these reports typically include discussions of its senior housing operating portfolio, outpatient medical and research assets, and the demographic and regulatory environment relevant to its properties.
Investors can also use SEC filings to track matters such as dividend practices, debt covenants, and the terms of public offerings or credit agreements. On Stock Titan, AI-powered tools summarize lengthy filings, highlight key sections and surface important changes across reporting periods, helping users interpret complex documents more efficiently. Real-time updates from the SEC’s EDGAR system mean that new Ventas filings, including 10-K, 10-Q, 8-K and related exhibits, are available promptly, while Form 4 and other ownership reports can be consulted to analyze insider transactions and equity-based compensation activity associated with VTR.
Ventas, Inc. reported strong first quarter 2026 results driven by its senior housing operating portfolio. Attributable net income was $55.9 million, or $0.11 per diluted share, up from $46.9 million or $0.10 per share a year earlier.
Nareit FFO per share rose to $0.90 from $0.85, and Normalized FFO per share increased to $0.94 from $0.86, a 9% gain. Total revenues grew to $1.66 billion from $1.36 billion, supported by a more than 15% increase in Same-Store Cash NOI in the SHOP segment and 8.7% growth in total Same-Store Cash NOI.
The company closed $1.7 billion of senior housing investments year to date and raised its 2026 investment target to $3 billion. Ventas improved its Net Debt-to-Further Adjusted EBITDA to 5.0x and reported $5.5 billion of liquidity. Based on the strong start to the year, it increased full-year 2026 guidance for Attributable Net Income, Nareit FFO and Normalized FFO per share.
Ventas, Inc. director Maurice S. Smith reported acquiring small amounts of common stock units through compensation deferral programs. On April 16, 2026, he received 59.316 and 66.742 common stock units, both tied to dividend equivalents under non-employee director deferral arrangements and valued at the closing price of $85.51 per share on the grant date.
These units are payable solely in common stock under the terms of the company’s cash and equity award deferral programs. Following these awards, Smith directly holds a total of 28,675.671 shares of Ventas common stock.
Ventas, Inc. director Sumit Roy reported acquiring additional common stock units through dividend-equivalent awards, not open-market purchases. On April 16, 2026, he received 49.717 units and 66.742 units of common stock at a reference price of $85.51 per share under company director deferral programs. These awards, payable solely in common stock pursuant to his deferral elections, increased his directly held common stock to 22,357.224 shares.
Ventas, Inc. director Joe Vasquez Rodriguez Jr. received an equity award tied to his board compensation. He acquired 41.221 shares of common stock on April 16, 2026, valued at $85.51 per share, through units granted under the company’s Non-Employee Directors' Equity Award Deferral Program.
These units were credited as dividend equivalents on the company’s common stock and are payable solely in stock, under the terms of his deferral election and the program. Following this award, he directly holds 7,847.719 shares of Ventas common stock.
Ventas director Marguerite M. Nader received an equity award tied to dividend equivalents. On the dividend paid April 16, 2026, she acquired 66.742 common stock units under Ventas, Inc.’s Non-Employee Directors' Equity Award Deferral Program, valued at the closing price of $85.51 per share, bringing her directly held common stock to 21,424.958 shares.
Ventas, Inc. director Roxanne M. Martino acquired 188.32 shares of common stock through a grant under the company’s Non-Employee Directors' Cash Compensation Deferral Plan. The units were credited as dividend equivalents tied to the dividend paid on April 16, 2026 at a closing price of $85.51 per share.
Following this automatic, compensation-related acquisition, Martino directly holds a total of 64,081.021 shares of Ventas common stock.
Ventas, Inc. director Matthew J. Lustig acquired additional common stock units through company deferral programs tied to dividends. He received 229.231 units and 66.742 units of common stock, both valued at a closing price of $85.51 per share on the grant date. These awards were credited as dividend equivalents under the Non-Employee Directors' Cash Compensation Deferral Plan and the Non-Employee Directors' Equity Award Deferral Program and are payable solely in common stock. Following these grants, Lustig directly holds 92,958.712 shares of Ventas common stock.
Ventas, Inc. director Michael J. Embler received additional common stock units as compensation linked to dividends. On the grant date, he acquired 66.742 units of common stock at a closing price of $85.51 per share through the company’s Non-Employee Directors' Equity Award Deferral Program.
The units were credited as dividend equivalents on the dividend paid April 16, 2026 and are payable solely in common stock under his deferral election and the Program’s terms. After this award, Embler directly holds a total of 14,654.958 shares of Ventas common stock.
Barnes Melody C reported acquisition or exercise transactions in this Form 4 filing.
Ventas, Inc. director Melody C. Barnes received a grant of common stock units credited as dividend equivalents under the company’s Non-Employee Directors' Equity Award Deferral Program. The award totaled 66.742 shares based on the $85.51 closing price on April 16, 2026, increasing her direct holdings to 33,259.958 shares of common stock.
Ventas, Inc. director Maurice S. Smith received an award of 457.261 common stock units on April 1, 2026 under the company’s Non-Employee Directors' Cash Compensation Deferral Plan. The units were granted in lieu of director fees and are payable solely in common stock.
The grant was valued at $82.01 per share, representing the closing price of Ventas common stock on the grant date. Following this compensation-related acquisition, Smith directly holds a total of 28,549.613 shares of Ventas common stock.